Stiolto Respimat is a prescription drug approved by the Food and Drug Administration (FDA) as long-term, once-daily maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease (COPD). Stiolto Respimat is a combination drug composed of Tiotropium bromide and Olodaterol.
Tiotropium bromide is an anticholinergic. Olodaterol is a long-acting beta2-adrenergic agonist (LABA). Both drugs are long-acting bronchodilators. Both drugs are believed to work by relaxing and dilating the airways, making it easier to breathe.
How do I take it?
Stiolto Respimat is taken once daily.
Stiolto Respimat comes in the form of an inhalation... read more